Skip to main content
Caplight Logo









Genomate Health

Genomate Health

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://genomate.health/

Last Round

VC Round

May 5, 2025

Total Funding Raised

$2.25M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Genomate Health is a digital health company that provides a clinically validated, AI-powered computational platform to help oncologists make personalized cancer treatment decisions.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

precision medicineclinical decision supportoncology AIgenomic analysismolecular diagnosticsAI oncologycancer treatment matchingpersonalized medicineSaaSclinical decision support systemCDSSmedtechdigital healthhealthcare analyticsAI-driven diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Genomate Health Comparables

Compare Genomate Health with similar companies based on industry and business-model similarity.

Genomate Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CureMatch
89%
Clarified Precision Medicine
84%
GenomOncology
84%

Genomate Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMay 5, 2025
VC RoundFeb 11, 2025
SeedApr 16, 2024

Key People

Founding team and executive leadership

Istvan Petak

Founder and Chief Scientific Officer

Founding Team

Nabil Hafez

Chief Executive Officer

Executive Team

Peter Filotas

Chief Technology Officer

Executive Team

Genomate Health Investors

Notable investors and investment history

Genomate Health investors
InvestorRounds
Plug and Play Tech CenterVC Round
Mayo Clinic PlatformSeed
STRT HoldingVC Round
OktogonVC Round
Accessio Equity PartnersVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 346% MoM, reaching 10.8K.

  • Jul 25, 2026

    Monthly visitors increased 33% MoM.

Recent news

Latest coverage and updates

  • integrates_withJul 27, 2026

    Genomate Health, Inc. integrated with Euformatics on Jul 27th '26.

  • partners_withJul 20, 2026

    Genomate Health Inc partnered with Inflexa, Inc. on Jul 20th '26.

  • receives_awardJul 20, 2026

    Genomate Health Inc receives award Future Unicorn Award of DIGITALEUROPE.

Genomate Health Filings

Explore SEC and related filing metadata, where available.

Genomate Health filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Genomate Health's valuation, stock price, and market status.

Is Genomate Health a public or private company?

Genomate Health is a private company.

What is the current stock price of Genomate Health?

Genomate Health is a private company with no public stock price. No recent secondary market data is available.

How much is Genomate Health worth (valuation)?

Valuation information for Genomate Health is not publicly available.

Can I buy Genomate Health stock?

Genomate Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Genomate Health's last funding round?

Genomate Health's most recent funding round was VC Round on May 12, 2025.

Who are the main investors in Genomate Health?

Investor information for Genomate Health is not publicly disclosed.

Will Genomate Health IPO soon?

No public IPO plans have been announced for Genomate Health.

How can I track Genomate Health secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Genomate Health's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range27
Year Founded2022
Last FundingMay 5, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?